Sudip Sen

Dr. Sudip Sen

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
SSSudip Sen
Sudip Sen
HSHimani Sharma
Himani Sharma
NSNeeta Singh
Neeta Singh

1 September 2005 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
HSHimani Sharma
Himani Sharma
SSSudip Sen
Sudip Sen
NSNeeta Singh
Neeta Singh
The aim of this study was to develop novel and less toxic therapy for human head and neck squamous cell carcinoma (HNSCCs) and to investigate the mechanism of quercetin-induced apoptosis in human l...

1 February 2008 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
HSHimani Sharma
Himani Sharma
PDPalika Datta
Palika Datta
ASArchna Singh
Archna Singh
SSSudip Sen
Sudip Sen
NBNarendra Kumar Bhardwaj
Narendra Kumar Bhardwaj
NSNeeta Singh
Neeta Singh

1 July 2003 in Biological Psychology
Verified
Journal Article
Closed access
HSHimani Sharma
Himani Sharma
SSSudip Sen
Sudip Sen
ASArchna Singh
Archna Singh
NBNarendra Kumar Bhardwaj
Narendra Kumar Bhardwaj
VKVinod Kochupillai
Vinod Kochupillai
NSNeeta Singh
Neeta Singh

1 July 2005 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
PDF file
HSHimani Sharma
Himani Sharma
SSSudip Sen
Sudip Sen
Lorenzo Lo MuzioLorenzo Lo Muzio
Lorenzo Lo Muzio
Maria A MariggiòMaria A Mariggiò
Maria A Mariggiò
NSNeeta Singh
Neeta Singh
We have earlier reported that the inhibition of apoptosis in head and neck squamous cell carcinomas (HNSCC) is because of upregulated expression of Bcl-2, Bcl-XL and Survivin. Hence, we addressed the question whether antisense approach towards these inhibitors of apoptosis could restore the apoptosis in HNSCC. Further, we wanted to see whether chemotherapeutic efficacy of Cisplatin and Etoposide could be enhanced by using these drugs in combination with antisense oligonucleotides in human laryngeal carcinoma HeP2 and tongue carcinoma Cal27 cells. The effect of these antisense oligonucleotides was examined on the mRNA expression by RT-PCR and on protein expression by Western blotting. Apoptosis was measured by flowcytometry, TUNEL assay and caspase-3 activity assay. Treatment of HeP2 and Cal27 cells with 400nM antisense oligonucleotides against Bcl-2, Bcl-XL and Survivin for 48 hrs decreased their expression both at the mRNA as well as at the protein level, resulting in the induction of apoptosis. Treatment of HeP2 and Cal27 cells with these antisense oligonucleotides augmented Cisplatin and Etoposide induced apoptosis. Our findings emphasize the importance of Bcl-2, Bcl-XL and Survivin as survival factors in HNSCC cells. Antisense treatment against these survival factors in combination with lower doses of chemotherapy offers potential as a less toxic chemoadjuvant therapy.

1 April 2003 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NKNeeru Khanna
Neeru Khanna
SSSudip Sen
Sudip Sen
HSHimani Sharma
Himani Sharma
NSNeeta Singh
Neeta Singh